about
P361
Aldo-keto reductase family 7 member A2Carbonyl reductase 4Aldo-keto reductase family 1 member C3Aldo-keto reductase family 1 member C2Aldo-keto reductase family 1 member C1Aldo-keto reductase family 1 member A1Aldo-keto reductase family 1 member B10Aldo-keto reductase family 1, member C18Aldo-keto reductase family 1, member B8Aldo-keto reductase family 1, member C6Aldo-keto reductase family 1, member A1 (aldehyde reductase)Carbonyl reductase 4Aldo-keto reductase family 7, member A5 (aflatoxin aldehyde reductase)Aldo-keto reductase family 1, member B3 (aldose reductase)Aldo-keto reductase family 1 member BAldo-keto reductase family 1 member BAldo-keto reductase family 1, member C3Aldo-keto reductase family 1, member C14Carbonyl reductase 4Aldo-keto reductase family 1 member A1Aldo-keto reductase family 1, member C1Aldo-keto reductase family 1, member C14Aldo-keto reductase family 1 member C4Aldo-keto reductase family 1 member A1Carbonyl reductase 4Aldose reductase
P682
Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicinDnrD cyclase involved in the biosynthesis of doxorubicin: purification and characterization of the recombinant enzymeTwo allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin.
P921
Q21097418-3B3600EC-D120-46EE-A189-97D8B1003D4CQ21102252-F69E0C73-4CDF-4FFD-8248-06DC840B2772Q21105060-334018CD-4DFC-45C0-BEA2-0E0418C33810Q21105060-3D99FFF3-3D78-4826-99F0-E91A726E0E6AQ21105063-DED17505-659A-4830-8613-3B529F06124FQ21105077-CC95C2E4-786D-47F9-BB1C-3F911FBCE164Q21130492-821B8BC3-72D3-465B-8C1F-88C17FC3A28FQ21132364-2E837DE9-D3F9-4128-B130-C30AAD61122CQ21421968-7B869E27-5857-41C1-99CF-6A1D93474634Q21421968-C38D2657-BED5-4A7F-A81E-0E4EA2090E18Q21428858-5EE854B7-B51E-4205-8894-8604E8EBF804Q21433466-89A34FA4-8B1B-43C9-90FD-2802ACAE2D38Q21433466-CDA0D9E1-D9C5-41BA-96A3-541F06EDCB0DQ21494810-3D5AF35C-E156-408F-8222-F495D000EC76Q21494810-DB97BE8A-A47D-48A0-89D5-DCE34A9C8B99Q21498074-E83FD5FA-8724-4E28-B490-C2D93C138722Q21499036-5419C069-2EE4-4777-886D-7D0A8C88B3B4Q21983463-FEC29D4E-FB87-4136-A571-743200EEEC42Q22679043-91897CD8-8309-4A9A-8755-B12862BC7515Q28556355-17355108-4208-4DC2-9A9C-615F2D6EC945Q28557657-75D8B900-5893-45F5-947F-BA1C65E2810FQ28560401-40130516-B5BA-4821-A563-4FBBFA79A6DAQ28560817-E8FBCC90-7DCE-48CC-98BA-DF42CCC1BBC7Q28562220-A5B57AB7-52A2-406C-AD87-931E19922526Q29526758-647B65B0-8A30-4424-9493-4B23989086DAQ29529690-39321851-666C-49D6-A20A-544A20DBA892Q4634197-56C6286A-5831-4026-92C0-837EF6AC8CB2Q4634197-EFF051FC-BF76-4350-B4A1-62671ADB7BDDQ55201073-777D80DB-8281-459B-951E-457369E2B0C3Q55201277-8F2C695E-AB86-463B-A75D-ED7A403E863EQ55204363-795C5809-CD87-4A0D-9453-D9234B835ECE
P682
description
The chemical reactions and pat ...... , used in cancer chemotherapy.
@en
biologisch proces
@nl
name
doxorubicin metabolic process
@en
type
label
doxorubicin metabolic process
@en
prefLabel
doxorubicin metabolic process
@en
P279
P279
P2888
P527
P686
GO:0044598